Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 11:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 769–792 of 3,240 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: SCHIZOPHRENIA 1 (Disorder)
Interventions: DSP-2342; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pyruvate Kinase Deficiency, Glucose 6 Phosphate Dehydrogenase Deficiency
Interventions: Vitamin C; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Kidney Disease, Chronic, End Stage Renal Disease, Kidney Replacement
Interventions: EPPComm Provider Training; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Livingston, New Jersey • Philadelphia, Pennsylvania

Conditions: Treatment Resistant Depression (TRD)
Interventions: aiTBS; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 247 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 3
States / cities: San Diego, California • New York, New York • Dallas, Texas

Conditions: COVID -19, Influenza A, Influenza B, Respiratory Synctial Virus, RSV, Rhinovirus
Interventions: Aptitude Medical Systems Respiratory Panel Test; Diagnostic Test
Lead sponsor: Aptitude Medical Systems; Industry
Eligibility: Not listed
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Trussville, Alabama

Conditions: Osteoarthritis (OA)
Interventions: Empowered Relief, "Self Management Strategies" handout; Behavioral
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Metastatic Pancreatic Cancer
Interventions: XNW28012; Drug
Lead sponsor: Evopoint Biosciences Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 8
States / cities: Detroit, Michigan • Grand Rapids, Michigan • Lake Success, New York + 5 more

Conditions: Knee Osteoarthritis, Arthritis Knee
Interventions: ZYNRELEF 400Mg-12Mg Extended-Release Solution, Ultrasound-Guided Adductor Canal Block, Ropivacaine 0.5% Injectable Solution; Drug · Procedure
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Pregnant People, Anxiety
Interventions: Remimazolam, Dexmedetomidine; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Type 2 Diabetes
Interventions: Continuous glucose monitor; Device
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 218 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Systemic Lupus Erthematosus, Fatigue, Exercise Training
Interventions: Personalized Home-Based High-Intensity Interval Training; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Influenza (Healthy Volunteers)
Interventions: Exposure to Donors with naturally acquired influenza virus infection; Other
Lead sponsor: University of Maryland, College Park; Other
Eligibility: 18 Years to 49 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: College Park, Maryland

Conditions: Intervention Group, Control Group
Interventions: Adult Wellbeing CheckUp (AWC), General Healthy Aging Information; Behavioral
Lead sponsor: BellAge Inc.; Industry
Eligibility: 60 Years and older
Enrollment: 496 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Sunnyside, New York

Conditions: Postoperative Facial Ecchymosis, Postoperative Facial Edema
Interventions: ELIXIR MD Photobiomodulation (PBM) System; Device
Lead sponsor: Elixir MD Inc; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Perinatal Anxiety, Perinatal Depression
Interventions: Patient Navigation (PN), Problem Solving Therapy (PST); Behavioral
Lead sponsor: American University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Primary Open Angle Glaucoma
Interventions: Rocklatan (netarsudil 0.02% and latanoprost 0.005%), Systane; Drug
Lead sponsor: Center for Sight Las Vegas; Other
Eligibility: 40 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Stress Disorders, Post-Traumatic, Pain, Chronic
Interventions: Mantram Repetition Program for PTSD + Pain, Health Education while Living with Pain; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: San Diego, California

Conditions: Covid19 Pneumonia
Interventions: EC-18, Placebo; Drug
Lead sponsor: Enzychem Lifesciences Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: The Bronx, New York • Warwick, Rhode Island

Conditions: Atherosclerotic Cardiovascular Disease (ASCVD), Coronary Artery Calcification
Interventions: AI-Detected CAC Notification and Care Facilitation; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 74 Years
Enrollment: 120,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 6
States / cities: Los Angeles, California • Pleasanton, California • Stanford, California + 3 more

Conditions: Irritable Bowel Syndrome (IBS-C)
Interventions: Transcutaneous Auricular Vagus Nerve Stimulation (ta-VNS), Sham Transcutaneous Auricular Vagus Nerve Stimulation; Device
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Well-Being (Psychological Flourishing), Internalizing Mental Health Symptoms, Substance Abuse
Interventions: Mindfulness and Identity-Based Micropractice, Control Condition Micropractice; Behavioral
Lead sponsor: Cornell University; Other
Eligibility: 16 Years to 26 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Cannabis Use
Interventions: Behavioral: Smart Talk Cannabis Awareness and Prevention; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 10 Years to 20 Years
Enrollment: 10,800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Pain, Postoperative
Interventions: AirSeal® Insufflation System (AIS), Lexicon AP 50/30 Insufflator; Device
Lead sponsor: SurgiQuest, Inc.; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Stamford, Connecticut

Conditions: Pregestational Diabetes, Type 2 Diabetes
Interventions: Exercise; Behavioral
Lead sponsor: Eastern Virginia Medical School; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Norfolk, Virginia

Search by objective public record fields.

Brain Imaging of DSP-2342

High-Dose Vitamin C in G6PDA and Pyruvate Kinase Deficiency: A Safety Study

Development and Test of a Communication Skills Training for Transplant Providers - Aims 2 & 3

Neuronavigated aiTBS for TRD

Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings

Empowered Relief Study

Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer

Zynrelef Versus Adductor Canal Block

Remimazolam Versus Dexmedetomidine for Sedation During Neuraxial

Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring

Home-Based High-Intensity Interval Training in Systemic Lupus Erythematosus

Evaluating Modes of Influenza Transmission 2b Baseline SAR

Innovative Web-based Service Platform Called Adult Wellbeing CheckUp (AWC) to Assess Older Adults Wellbeing, Obtain Evidence-based Recommendations, and Receive Support to Take Action.

Perioperative Photobiomodulation in Facial Plastic Surgery

Improving Perinatal Mental Health Through a Collaborative, Community Health Worker and Social Worker Intervention

Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)

Mantram Repetition Versus Health Education for Veterans With PTSD and Chronic Pain

Prevention of COVID-19 Infection to Severe Pneumonia or ARDS

Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)

Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C

Micropractices for Unhoused LGBTQ Youth

Smart Talk: Cannabis Awareness and Prevention Curriculum Evaluation

Gastrectomy at Low Pressure Trial - (GALPT)

Glucose Control in Type 2 Diabetes in Pregnancy